Immune Correlates and Mechanisms of Controlling NTS Bacteremia
免疫相关性和控制 NTS 菌血症的机制
基本信息
- 批准号:8026709
- 负责人:
- 金额:$ 38.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-10 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcquired Immunodeficiency SyndromeAdenovirusesAdultAfricaAgeAmericanAnimal FeedAnimal ModelAnimalsAntibodiesAntibody FormationAntigenic SpecificityAntigensArchitectureAttenuatedAutoimmune DiseasesB-LymphocytesBacteremiaBacteriaBiological AssayCD4 Positive T LymphocytesCarbohydratesCaspase-1CattleCell DeathCellsChildChronicClinical DataDataDefectDendritic CellsDetectionDevelopmentEcosystemEnvironmentEpidemicEpidemiologyFecesFigs - dietaryFlagellinGene TransferGoalsGrowthHIVHelminthsHistologicHistologyHost DefenseHourHumanIL10 geneImmuneImmune SeraImmune responseImmune systemImmunocompromised HostImmunoglobulin GImmunoglobulinsImmunosuppressive AgentsIndividualInfantInfectionInflammationInflammatoryInterleukin-10Interleukin-12InvadedLiposomesLiquid substanceLymphocyteMalariaMalignant NeoplasmsMalnutritionMeasuresMediatingMediator of activation proteinMesenteryModelingModificationMonitorMusOralPathogenesisPatientsPopulationPopulation StudyPredispositionPropertyProteinsReagentRiskRoleSalmonellaSalmonella infectionsScreening procedureSerumSpleenSplenomegalySurfaceSystemSystemic infectionT-LymphocyteTestingTissue SampleTissuesUnited StatesVaccinesVirulenceVirulentWestern BlottingWorkcytokinecytotoxicityfluorescence imaginggenetic regulatory proteinimmune functionin vivoindexinginterestintestinal epitheliumlymph nodesmacrophagemouse modelneutrophiloverexpressionpathogenresponsetooltransmission processwater quality
项目摘要
Non-typhoidal Salmonella (NTS) colonizes food animals and causes human gastroenterifis in the U.S., cosfing billions of dollars annually. NTS also causes bacteremia in immunocompromised individuals, including those with cancer or autoimmune diseases, at the extremes of age, or those taking immunosuppressive medicafions. HIV infected individuals and AIDS pafients are also at risk, and thus susceptibility to NTS bacteremia is a problem shared throughout the world. In tropical Africa, where HIV is epidemic, the populafion also suffers from malnutrition, poor water quality, and infestations with malaria and helminthes, all of which alter host immune responses and therefore suscepfibility to NTS infections. Although neither the host responses required for controlling NTS bacteremia nor the epidemiology of NTS infecfions in Africa are well studied, recent data indicates human-to-human transmission of NTS. Thus, an enlarging population of suscepfible hosts suffers NTS bacteremia and, through human-to-human transmission, exposes other hosts with immune systems variably compromised by additional infections, young age, or other insults; thereby creating a new host-pathogen 'ecosystem' in one part of the worid. This unique environment may be permissive for propagation of NTS strains with altered properties, especially in comparison with their NTS cousins from the U.S. where transmission most commonly occurs from food
animal to humans. This project will test interrelated hypotheses directed toward understanding immune mechanisms controlling NTS bacteremia and the attributes of bacterial strains arising in this unique environment: 1) altered immune detecfion, relevant to colonizing and causing bacteremia in immunocompromised hosts, has arisen in NTS strains as a result of human-to-human transmission, 2) interrelated immune functions, including T and B cell, macrophage and cytokine funcfions are important for controlling bacteremia, 3) specific immune defects, relevant to our study populations, facilitate NTS colonizafion/bacteremia, and 4) examining differenfial immune recognition of NTS isolates by bacteremic patients and their close contacts will aid us in establishing screening criteria for Salmonella carrier status and provide preliminary indicators of bacterial anfigens potentially useful for vaccines protecfive against bacteremia. This project is substanfially enhanced by reagents resulting from the work described in Projects 1 and 2, provides mechanistic data to aid in the interpretation of clinical data gathered in Project 1, and provides experimental systems for further evaluating strains of interest defined in Project 2.
在美国,非伤寒沙门氏菌(NTS)定植于食用动物并导致人类胃病,每年都要花上几十亿美元NTS还导致免疫功能低下个体的菌血症,包括患有癌症或自身免疫性疾病的个体、年龄极端的个体或服用免疫抑制药物的个体。HIV感染者和AIDS患者也处于危险中,因此对NTS菌血症的易感性是全世界共同的问题。在HIV流行的热带非洲,人们还遭受营养不良、水质差以及疟疾和蠕虫感染的困扰,所有这些都改变了宿主的免疫反应,从而改变了对NTS感染的抵抗力。虽然在非洲,控制NTS菌血症所需的宿主反应和NTS感染的流行病学都没有得到很好的研究,但最近的数据表明NTS存在人际传播。因此,越来越多的易感染宿主患有NTS菌血症,并且通过人与人之间的传播,使其他宿主的免疫系统受到额外感染、年轻或其他损伤的损害;从而在世界的一部分创造了新的宿主-病原体“生态系统”。这种独特的环境可能允许具有改变的特性的NTS菌株繁殖,特别是与来自美国的NTS表亲相比,在美国,传播最常见于食物
动物到人类该项目将测试相关的假设,旨在了解控制NTS菌血症的免疫机制以及在这种独特环境中产生的细菌菌株的属性:1)NTS菌株由于人-人传播而出现与在免疫受损宿主中定植和引起菌血症相关的免疫检测改变,2)相关的免疫功能,包括T和B细胞,巨噬细胞和细胞因子功能对于控制菌血症很重要,3)与我们的研究人群相关的特异性免疫缺陷,促进NTS定殖/菌血症,和4)检测菌血症患者及其密切接触者对NTS分离株的免疫识别差异,将有助于我们建立沙门氏菌携带者状态的筛查标准,并提供初步的可能用于疫苗预防菌血症的细菌抗原的指示剂。该项目通过项目1和2中所述工作产生的试剂得到了实质性增强,提供了有助于解释项目1中收集的临床数据的机制数据,并提供了用于进一步评价项目2中定义的目标菌株的实验系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRAD T COOKSON其他文献
BRAD T COOKSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRAD T COOKSON', 18)}}的其他基金
Caliper Life Sciences IVIS Lumina II imaging system
Caliper 生命科学 IVIS Lumina II 成像系统
- 批准号:
8246848 - 财政年份:2012
- 资助金额:
$ 38.27万 - 项目类别:
Host and pathogen-associated mechanisms of Yersinia survival in lumph nodes
耶尔森菌在肿块淋巴结中存活的宿主和病原体相关机制
- 批准号:
8236985 - 财政年份:2011
- 资助金额:
$ 38.27万 - 项目类别:
Host and pathogen-associated mechanisms of Yersinia survival in lumph nodes
耶尔森菌在肿块淋巴结中存活的宿主和病原体相关机制
- 批准号:
7675881 - 财政年份:2009
- 资助金额:
$ 38.27万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6285611 - 财政年份:2001
- 资助金额:
$ 38.27万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6488760 - 财政年份:2001
- 资助金额:
$ 38.27万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6691702 - 财政年份:2001
- 资助金额:
$ 38.27万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6836493 - 财政年份:2001
- 资助金额:
$ 38.27万 - 项目类别:
CD4+ T CELLS RESPONDING TO SALMONELLA INFECTION
CD4 T 细胞对沙门氏菌感染的反应
- 批准号:
6626383 - 财政年份:2001
- 资助金额:
$ 38.27万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 38.27万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 38.27万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 38.27万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 38.27万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 38.27万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 38.27万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 38.27万 - 项目类别:














{{item.name}}会员




